Dr Miele Cosmed GroupWAR:DMG 70 EBITDA Margin % is 8.08% as of Mar. 2026, which is 21% above its 10-year median of 6.66. GuruFocus rates WAR:DMG with a GF Score™ of 70/100 and a GF Value™ of zł3.84 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, Dr Miele Cosmed Group ranks worse than 55.2% on this metric.
Dr Miele Cosmed Group (WAR:DMG) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Dr Miele Cosmed Group EBITDA Margin % Related Terms
Dr Miele Cosmed Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Dr Miele Cosmed Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:DMG vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Dr Miele Cosmed Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Miele Cosmed Group EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Miele Cosmed Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Dr Miele Cosmed Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Miele Cosmed Group (WAR:DMG) has a EBITDA Margin % of 8.08% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dr Miele Cosmed Group and its competitors. This is 21% above median its historical median of 6.66. According to the industry distribution chart, Dr Miele Cosmed Group ranks #1078 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 55.2%.
Is Dr Miele Cosmed Group's EBITDA Margin % too high?
Dr Miele Cosmed Group's current EBITDA Margin % of 8.08% is 21% above median its 10-year median of 6.66. The Consumer Packaged Goods industry median EBITDA Margin % is 8.99. Dr Miele Cosmed Group's value of 8.08% is 10.1% below this industry median. Based on the distribution chart, Dr Miele Cosmed Group ranks #1078 out of 1953 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Dr Miele Cosmed Group has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Miele Cosmed Group's EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Dr Miele Cosmed Group ranks #1078 out of 1953 companies for EBITDA Margin %. This places Dr Miele Cosmed Group in the lower half of its industry. The industry median EBITDA Margin % is 8.99. Dr Miele Cosmed Group's value of 8.08% is 10.1% below this benchmark. While the company's 10-year median is 6.66 vs. the industry median of 8.99, Dr Miele Cosmed Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Miele Cosmed Group's current EBITDA Margin % of 8.08% is 10.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dr Miele Cosmed Group and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Miele Cosmed Group's current EBITDA Margin % is 8.08%, which is 21% above median its own 10-year median of 6.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Miele Cosmed Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Miele Cosmed Group (WAR:DMG) is currently considered Significantly Undervalued. The stock's GF Value™ is zł3.84, compared to a current price of zł2.31 — trading 39.8% below its estimated fair value. The current EBITDA Margin % is 8.08%, which is 21% above median its 10-year median of 6.66 and 10.1% below the Consumer Packaged Goods industry median of 8.99. Dr Miele Cosmed Group's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Dr Miele Cosmed Group (WAR:DMG), the current EBITDA Margin % is 8.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Miele Cosmed Group (WAR:DMG) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Miele Cosmed Group stock appears to be undervalued.
The current stock price of zł2.31 is trading 39.8% below its estimated GF Value™ of zł3.84.
GuruFocus considers Dr Miele Cosmed Group to be Significantly Undervalued.
Key valuation signals for WAR:DMG:
EBITDA Margin %: 8.08% (21% above median its 10-year median of 6.66)
GF Value™: zł3.84 vs. price of zł2.31 (39.8% below fair value)
Industry Position: 10.1% below the Consumer Packaged Goods median (#1078 of 1953)
No single metric tells the full story. See the WAR:DMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Miele Cosmed Group SA is engaged in manufacturing cosmetics and household chemicals for national and international retailers, fulfils consumer needs in the sector of personal care, hygiene and cleanliness. The company's brands include Apart, Biophen, Mole, Bobini, Sofin and Izo.
70GF Score
Get the complete analysis for WAR:DMG
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:DMG has been successfully added to your 
